526, 51 (2018).CrossRefGoogle ScholarPubMed Nakamura, M., Awaad, A., Hayashi, K., Ochiai, K., and Ishimura, K.: Thiol-organosilica particles internally functionalized with propidium iodide as a multicolor fluorescence and X-ray computed tomography probe and application for non-invasive functional gastrointestinal tract imaging
The medication reaches an equilibrium where the amount injected equals the amount eliminated weekly
According to the Wegovy (semaglutide 2.4 mg) label, alopecia was reported in 3.5% of patients versus 1.0% on placebo
Metabolic and Hormonal Factors Underlying endocrine conditions can significantly impair weight loss efforts: Hypothyroidism : Untreated or inadequately managed thyroid dysfunction slows metabolic rate and may blunt Wegovy's effectiveness Polycystic ovary syndrome (PCOS) : Insulin resistance and hormonal imbalances can make weight loss more challenging Cushing's syndrome : Excess cortisol promotes weight gain, particularly central adiposity Sleep disorders : Obstructive sleep apnoea and poor sleep quality disrupt metabolic hormones (leptin, ghrelin) that regulate appetite NICE guidance (CG189) recommends investigating potential secondary causes of obesity when weight loss interventions prove ineffective
